CONTINUE TO SITE

OR WAIT null SECS

Contraception Endometriosis Menopause Uterine Fibroids

ContraceptionEndometriosisMenopauseUterine Fibroids

Antifungal Resistance in Vulvovaginal Candidiasis (VVC) Infections, Alternative Treatment Options Better For Women Series Chlamydia Screening Post COVID-19 Consortium for Sexual Health and Wellness Enhanced Recovery for Cesarean Delivery: Perspectives From the Front Lines, Part 2 Management of Uterine Fibroids Mycoplasma Genitalium Infections NAMS 2021 Rationale for a New Method of Contraception

Antifungal Resistance in Vulvovaginal Candidiasis (VVC) Infections, Alternative Treatment OptionsBetter For Women SeriesChlamydia Screening Post COVID-19Consortium for Sexual Health and WellnessEnhanced Recovery for Cesarean Delivery: Perspectives From the Front Lines, Part 2Management of Uterine FibroidsMycoplasma Genitalium InfectionsNAMS 2021Rationale for a New Method of Contraception

Topics

View More Breast Cancer Curbside Consults Gynecology Infertility Labor and Delivery Legally Speaking Life Transitions Obstetrics Osteoporosis Practice Management Pregnancy and Birth Sexual Health Vulvovaginal Disease Well Woman

Breast CancerCurbside ConsultsGynecologyInfertilityLabor and DeliveryLegally SpeakingLife TransitionsObstetricsOsteoporosisPractice ManagementPregnancy and BirthSexual HealthVulvovaginal DiseaseWell Woman

About News

Media

Podcasts K-Casts Medical World News Quizzes Videos Viewpoints

PodcastsK-CastsMedical World NewsQuizzesVideosViewpoints

Conferences

Conference Coverage Conference Listing

Conference CoverageConference Listing

Publications

Contemporary OB/GYN® Journal Digital Supplements Peer Reviewed Articles Supplements and Featured Publications

Contemporary OB/GYN® JournalDigital SupplementsPeer Reviewed ArticlesSupplements and Featured Publications

CME/CE

Resources

Physician Fact Sheets Job Board

Physician Fact SheetsJob Board

eNewsletter Print Subscription

eNewsletterPrint Subscription

Editorial Board

Meet the Board

Partnerships

Advertise
Contact Us
Job Board
Editorial
Terms of Use
Privacy Policy
Do Not Sell My Personal Information

Resource Centers

Contraception
Endometriosis
Menopause
Uterine Fibroids

Spotlight

Antifungal Resistance in Vulvovaginal Candidiasis (VVC) Infections, Alternative Treatment Options
Better For Women Series
Chlamydia Screening Post COVID-19
Consortium for Sexual Health and Wellness
Enhanced Recovery for Cesarean Delivery: Perspectives From the Front Lines, Part 2
Management of Uterine Fibroids
Mycoplasma Genitalium Infections
NAMS 2021
Rationale for a New Method of Contraception

TopicsSee All >

Breast Cancer
Curbside Consults
Gynecology
Infertility
Labor and Delivery
Legally Speaking
Life Transitions
Obstetrics
Osteoporosis
Practice Management
Pregnancy and Birth
Sexual Health
Vulvovaginal Disease
Well Woman

Advertise
Contact Us
Job Board
Editorial
Terms of Use
Privacy Policy
Do Not Sell My Personal Information

What drives prophylactic mastectomy?

December 6, 2012

Fear-not clinical indications-may be the driving force in women's decision-making about contralateral prophylactic mastectomy (CPM). That is the surprising conclusion from a population-based study presented by investigators from Michigan at the 2012 American Society of Clinical Oncology (ASCO) Quality Symposium in San Diego.